HZHong Zeng

Hong Zeng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hong Zeng has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Li Cheng

    Department of Rehabilitation Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    5 shared publications
  • Yijia Wang

    Department of Rehabilitation Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    4 shared publications
  • Bin Cai

    Department of Rehabilitation Medicine, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 500 Quxi Road, Shanghai, 200011, China

    3 shared publications
  • Jinwu Wang

    Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

    3 shared publications
  • Xintong Zhu

    Department of Rehabilitation Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    3 shared publications
  • Yang Yang

    Department of Rehabilitation Medicine, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 500 Quxi Road, Shanghai, 200011, China

    3 shared publications

Latest Publications

  • Open Access

    Bidirectional regulatory effects of frequency-dependent splenic apex electrical stimulation on peripheral immune suppression and central neural repair after spinal cord injury

    by Hao Sun, Yijia Wang, Shujing Lai, Xintong Zhu, Li Cheng, Mengting Liang, Xia Bi, Hong Zeng, Jiaxue Zhu

    The regulatory network of the spleen, a densely innervated immune hub, undergoes pathological remodeling following spinal cord injury. Whether targeted electrical stimulation of the spleen at specific frequencies can reverse peripheral immune suppression or improve the central immune system remains unclear. The aim of this study was to elucidate the previously unexamined effects and differential regulatory mechanisms of transsplenic apex electrical stimulation (10, 50, and 100 Hz) on peripheral immune suppression and spinal cord homeostasis after spinal cord injury. A mouse model of T3 spinal cord injury was established and systematically evaluated through functional assessments, splenic/spinal cord transcriptome sequencing, weighted gene co-expression network analysis, Short Time-series Expression Miner analysis, and multiomics validation to investigate the frequency-dependent effects of stimulation. The effects of the electrical stimulation exhibited significant frequency dependence. Specifically, 100 Hz electrical stimulation effectively restored the impaired bacterial clearance capacity in the host ( P < 0.001), reversed the suppression of adaptive immune-related gene modules in the spleen, and shifted immune responses toward T helper 17 (Th17) cell-axis remodeling. This was accompanied by upregulation of the expression of key hub genes such as those encoding integrin alpha x, CC chemokine receptor 6, Fc receptor-like 5, leukocyte immunoglobulin-like receptor subfamily A member 5, and Th17 signature cytokines such as interleukin-17, interleukin-23, and transforming growth factor-beta. In the spinal cord, 100 Hz electrical stimulation suppressed pro-inflammatory pathways such as nuclear factor-kappa B and tumor necrosis factor-alpha while activating neurorepair pathways, such as glutamatergic synapses. In contrast, 10 Hz electrical stimulation failed to alleviate peripheral immune suppression and exacerbated splenic immunosuppression and central neuroinflammation. These findings demonstrate that electrical stimulation of the splenic apex exerts frequency-dependent, bidirectional modulatory effects, with 10 and 100 Hz eliciting contrasting neuroimmune responses. Specifically, 100 Hz electrical stimulation activates the splenic Th17 immune axis, offering a potential mechanism to reverse spinal cord injury-induced immunodeficiency and neurological damage. Identifying the stimulation frequency as a critical therapeutic variable provides a foundation for developing frequency-optimized integrated neuroimmunomodulatory strategies for the treatment of spinal cord injury.

  • Open Access

    Varenicline-mediated cholinergic activation through α4β2 nAChR inhibits microglial neuroinflammation and alleviates neuropathic pain and depression following spinal cord injury

    by Li Cheng, Shujing Lai, Yijia Wang, Xintong Zhu, Shaoshuai Song, De-Zhi Lu, Yang Yang, Li-Li Xu, Bin Cai, Jinwu Wang, et al.

    Spinal cord injury (SCI) often leads to neuropathic pain. Chronic pain is frequently comorbid with depression and is often refractory, becoming a focal point in clinical and basic research. Neuroprotective pathways activated by nicotinic acetylcholine receptors (nAChRs) are attractive therapeutic targets for neurodegenerative diseases. The α4β2 nAChR agonist varenicline has been shown to alleviate pain, reduce functional disability, and improve cognitive aspects; however, understanding of its effects and mechanisms on neuropathic pain following SCI remains limited. We hypothesize that varenicline regulates cholinergic activity in microglia by activating α4β2 nAChRs, thereby inhibiting neuroinflammation. We aimed to elucidate this mechanism to provide new therapeutic strategies for alleviating comorbid neuropathic pain and depression following SCI. We used a rat T3 spinal cord compression injury model. Behavioural assessments, immunofluorescence, and transcriptomics were employed to investigate the effects of varenicline on mechanical and cold hypersensitivity as well as changes in negative mood in T3-SCI model rats. We analysed the expression of sensory afferent neurons and cholinergic neurons in the dorsal horn of the spinal cord among the different treatment groups. Additionally, we assessed the impact of varenicline on neuroinflammation and nAChRs following SCI. Following T3-SCI, the expression of nAChRs, including acetylcholine (ACh) neurotransmitter vesicles, ACh transporters, ACh metabolism enzymes, α4β2 nAChRs, and α7 nAChRs, and cholinergic activity were significantly suppressed, accompanied by an increase in microglia-dominated neuroinflammation. Varenicline pretreatment significantly enhanced impaired cholinergic neurotransmission and α4β2 nAChR expression following SCI; furthermore, it simultaneously inhibited the widespread activation and proliferation of microglia/macrophage-mediated neuroinflammation. Varenicline suppressed the sprouting of calcitonin gene-related peptide afferent fibres in the dorsal horn of the spinal cord after SCI. Additionally, varenicline reduced pain hypersensitivity and negative emotional aspects of depression following SCI. Varenicline also improved the Th1/Th2 immune balance after SCI. Varenicline can activate α4β2 nAChRs on neurons and enhance cholinergic activity after SCI. It is also associated with a significant suppression of widespread microglia-mediated neuroinflammation and the promotion of immune balance between Th1 and Th2 cells following injury. Moreover, varenicline appears to alleviate neuropathic pain and the negative emotional components of depression after SCI.

  • Open Access

    Sex-dependent mechanisms of neuropathic pain after spinal cord injury in rats: An integrated analysis based on transcriptomic and metabolomic profiling

    by Li Cheng, Peihui Zhou, Yijia Wang, Xintong Zhu, Yang Yang, Bin Cai, Hong Zeng, Li Wang

    Neuropathic pain following spinal cord injury is characterized by persistent spontaneous pain and evoked pain responses, such as mechanical allodynia and thermal hyperalgesia. Although inflammatory and metabolic reprogramming has been implicated in central sensitization, the sex-dependent molecular mechanisms underlying spinal cord injury-induced neuropathic pain remain insufficiently understood. Therefore, this study used an integrated analysis of transcriptomics and metabolomics to investigate the mechanisms underlying sex differences in neuropathic pain after spinal cord injury in rats. We established a rat model of T3 lateral hemisection spinal cord injury and assessed behavioral outcomes on the basis of integrated transcriptomic and metabolomic profiling. Both male and female rats developed significant mechanical and thermal hypersensitivity after spinal cord injury, confirming successful induction of neuropathic pain. However, unbiased multi-omics analyses revealed distinct sex-dependent molecular programs. Male rats exhibited alterations in calcium signaling, serine metabolism, and sphingolipid metabolic pathways, whereas female rats showed prominent changes in T cell receptor signaling and histidine metabolism. These findings suggest that immune–metabolic interactions diverge between sexes and may underlie the observed differences in spontaneous pain chronification after spinal cord injury. Our study highlights the importance of sex-dependent mechanisms in shaping neuroimmune and metabolic responses following spinal cord injury and provides novel insights into the molecular basis of central sensitization in spontaneous pain.

  • Top Cited Papers
    Open Access

    Nerve–bone crosstalk manipulates bone organoid development and bone regeneration: A review and perspectives

    by Shaoshuai Song, Jingyi Zhang, Ya Fang, Wenxing Li, Hong Zeng, Zhen Fang, Tianchang Wang, Youzhuan Xie, Chaozong Liu, Jinwu Wang

    As an innovative regenerative medicine technology, bone organoids represent a promising therapy for refractory bone injury repair, whereas the key to fabricating bone organoids is grounded in the utilization of biomaterials with osteogenesis cues. Considering the intricate crosstalk between neurons and osteocytes would support bone organoid development and bone wound healing, it is extremely essential to predicate biomaterial design and osteo-organoid construction on understanding the roles of neural growth in ossification center formation and bone-like tissue development. Therefore, this review presents the recent advances of bone organoids with innervated ossification centers after the detailed introduction in the nerve–bone crosstalk. Beginning with the exploration of underlying interaction mechanisms within the osteogenic microenvironment, the importance of the nerve–bone crosstalk on skeleton development and bone regeneration is emphasized at first. The following discussions mainly include diverse biomaterial strategies designed to enhance osteogenesis through early innervation, such as the incorporation of bioactive minerals, controlled release of neurotrophic factors, and exosome-mediated nerve regeneration. Last but not least, the review highlights the advanced technologies in fabricating tissue-engineered bone organoids, with a focus on the applications of cell-laden and multicellular 3D-bioprinted bone microtissues for constructing bone organoids with neurovascularization. These insights are critical to the development of novel biomaterials to construct innervated osteo-organoids, with significant implications for future clinical applications, while also exploring the potential to advance bone regenerative therapies through enhanced nerve–bone crosstalk and laying the foundation for innovative translational research in this field.


  • Open Access

    Unbiased multitissue transcriptomic analysis reveals complex neuroendocrine regulatory networks mediated by spinal cord injury-induced immunodeficiency

    by Hong Zeng, Li Cheng, De-Zhi Lu, Shuai Fan, Ke-Xin Wang, Li-Li Xu, Bin Cai, Mou-Wang Zhou, Jin-Wu Wang

    Background: Spinal cord injury (SCI), which causes loss of sensory and motor function in the body below the level of injury, is a devastating disease of the central nervous system. SCI leads to severe secondary immunosuppression, called SCI-induced immunodeficiency syndrome (SCI-IDS), which is characterized by increased susceptibility to infection and further exacerbates neurological dysfunction. Several studies have suggested that SCI-IDS is an independent risk factor for poor neurological prognosis. SCI-IDS predominantly occurs following injury above the T5 levels and eventually leads to systemic immune failure, possibly via the sympathetic–adrenal medullary axis and the hypothalamic‒pituitary‒adrenal (HPA) axis. However, the mechanism remains unclear. Methods and objectives: The concentrations of adrenocorticotropic hormone and cortisol in plasma, as well as changes in sympathetic activity (blood pressure and catecholamine levels in plasma), were assessed in rats in the high-level (T3) spinal cord injury (T3-SCI) group and the low-level (T10) spinal cord injury (T10-SCI) group. Second, the differential regulation of the gene network between the sympathetic–adrenal medullary axis and the HPA axis was explored by histology and multitissue transcriptomics, and the neuroendocrine–immune network associated with SCI-IDS was further elucidated. Results: The spleen and thymus gland, which are secondary immune organs, were significantly atrophied in rats in the T3-SCI group, and the white pulp of the spleen was significantly atrophied. The level of cortisol, which is mediated by the adrenal glands, was markedly elevated, but norepinephrine levels were markedly decreased. There was no difference in adrenocorticotropic hormone expression between any of the groups. The transcriptome analysis results showed that the downregulated differentially expressed genes (DEGs) in the T3-SCI group were enriched in the GO term immunoregulation, indicating that splenic immune function was markedly impaired after high-level SCI. The upregulated DEGs in the hypothalamus (hub genes: Nod2, Serpine1, Cebpb, Nfkbil1, Ripk2, Zfp36, Traf6, Akap8, Gfer, Cxcl10, Tnfaip3, Icam1, Fcgr2b, Ager, Dusp10, and Mapkapk2) were significantly enriched in inflammatory pathways, and the downregulated genes (hub genes: Grm4, Nmu, P2ry12, rt1-bb1, Oprm1, Zfhx2, Gpr83, and Chrm2) were enriched in pathways related to inhibitory Gi-mediated G protein-coupled receptor (Gi-GPCR) neurons and neuropeptide changes. The upregulated genes in the adrenal glands (hub genes: Ciart, per2, per3, cry1, and cry2) were enriched in cortisol secretion and circadian rhythm changes, and the downregulated genes (hub genes: IL7r, rt1-bb, rt1-bb1, rt1-da, rt1-ba, cd74, cxcr3, vcam1, ccl5, bin1, and IL8) were significantly enriched in MHC-mediated immune responses. Conclusions: To explore the possible mechanism underlying SCI-IDS, this study assessed the differential regulation of the gene network associated with neuroendocrine immunity after SCI. Progressive neuroinflammation spreads after injury, and neurotransmission through Gi-mediated G protein-coupled receptors in the HPA axis and neuropeptide production by the hypothalamus are inhibited. Disruption of the connection between the hypothalamus and the adrenal glands causes autonomous regulation of the adrenal glands, disturbance of circadian rhythm and finally hypercortisolemia, leading to general suppression of peripheral adaptive immunity. Neuraxial nerve inflammation caused by SCI persists indefinitely, blocking nerve repair; persistent system-wide immunosuppression in the periphery results in increased susceptibility to infection, leading to poor neurological prognosis.


  • Development and Application of Three-Dimensional Bioprinting Scaffold in the Repair of Spinal Cord Injury

    by Dezhi Lu, Yang Yang, Pingping Zhang, Zhenjiang Ma, Wentao Li, Yan Song, Haiyang Feng, Wenqiang Yu, Fuchao Ren, Tao Li, et al.

    Spinal cord injury (SCI) is a disabling and destructive central nervous system injury that has not yet been successfully treated at this stage. Three-dimensional (3D) bioprinting has become a promising method to produce more biologically complex microstructures, which fabricate living neural constructs with anatomically accurate complex geometries and spatial distributions of neural stem cells, and this is critical in the treatment of SCI. With the development of 3D printing technology and the deepening of research, neural tissue engineering research using different printing methods, bio-inks, and cells to repair SCI has achieved certain results. Although satisfactory results have not yet been achieved, they have provided novel ideas for the clinical treatment of SCI. Considering the potential impact of 3D bioprinting technology on neural studies, this review focuses on 3D bioprinting methods widely used in SCI neural tissue engineering, and the latest technological applications of bioprinting of nerve tissues for the repair of SCI are discussed. In addition to introducing the recent progress, this work also describes the existing limitations and highlights emerging possibilities and future prospects in this field.